Citizens Downgrades Terns Pharma to Market Perform

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

Citizens analyst Silvan Tuerkcan downgrades Terns Pharma (NASDAQ:TERN) from Market Outperform to Market Perform.

Comments

No comments yet. Be the first!